Vectura Group plc
Richard Poole has a strong background in the pharmaceutical industry. Richard started their career as a Quality Assurance Analyst at GSK in 1998, where they conducted release testing for dry powder inhalers, tablets, and capsules. In 2001, they joined Aventis Pharma as an Inhalation Scientist, focusing on testing and method development for dry powder inhalers and metered dose inhalers. In 2004, they became a Scientific Team Leader at Vectura Group, where they managed early-stage work and led a scientific team until their promotion to Senior Manager of Pharmaceutical Development in 2017. In this role, they oversaw the development of dry powder inhalers, ensuring quality data for regulatory submissions. Currently, they serve as the Director of the Centre of Excellence for Inhaled Product Solutions at Vectura Group.
Richard Poole attended The University of Sheffield from 1995 to 1998, where they obtained a Bachelor of Science (BSc) degree in Pharmacology.
This person is not in any offices